(NASDAQ: NEPH) Nephros's forecast annual earnings growth rate of 6.94% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 46.37%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.81%.
Nephros's earnings in 2025 is $1,481,000.On average, 4 Wall Street analysts forecast NEPH's earnings for 2025 to be $1,192,314, with the lowest NEPH earnings forecast at $1,145,556, and the highest NEPH earnings forecast at $1,227,382. On average, 3 Wall Street analysts forecast NEPH's earnings for 2026 to be $1,625,882, with the lowest NEPH earnings forecast at $1,562,122, and the highest NEPH earnings forecast at $1,673,703.
In 2027, NEPH is forecast to generate $2,276,235 in earnings, with the lowest earnings forecast at $2,186,971 and the highest earnings forecast at $2,343,184.